| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |